The Hematopoietic Cell Transplant Pharmacist: A Call to Action

Recently, the required training and credentials for as well as the various roles of the hematopoietic cell transplant (HCT) pharmacist have been endorsed by the leading organizations in cellular therapy, the American Society of Transplant and Cellular Therapy and the European Society of Blood and Bo...

Full description

Saved in:
Bibliographic Details
Main Author: Amber Clemmons (Author)
Format: Book
Published: MDPI AG, 2020-01-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_8b2645c6130f47a092ed1c624b90922c
042 |a dc 
100 1 0 |a Amber Clemmons  |e author 
245 0 0 |a The Hematopoietic Cell Transplant Pharmacist: A Call to Action 
260 |b MDPI AG,   |c 2020-01-01T00:00:00Z. 
500 |a 2226-4787 
500 |a 10.3390/pharmacy8010003 
520 |a Recently, the required training and credentials for as well as the various roles of the hematopoietic cell transplant (HCT) pharmacist have been endorsed by the leading organizations in cellular therapy, the American Society of Transplant and Cellular Therapy and the European Society of Blood and Bone Marrow Transplantation. While these documents establish the roles a HCT pharmacist can fulfill within the multi-disciplinary team, few reports have evaluated the impact of the HCT pharmacist on clinical, financial, or quality outcomes. Further, a paucity of information has been reported on types of practice models, such as the use of collaborative practice agreements, or described effective methods to overcome the barriers to the increased utilization of HCT pharmacists. Herein, a brief summary of available information is provided to aid readers in understanding the state of the science for pharmacists practicing in this specialty with the goal to stimulate further research to justify the roles of HCT pharmacists and the correlation of such research to various outcome measures. Practitioners are encouraged to build upon this existing knowledge to create the novel integration and elevation of pharmacy practice to improve outcomes for patients, providers, and payors. 
546 |a EN 
690 |a bone marrow 
690 |a clinical pharmacy service 
690 |a hematopoietic 
690 |a responsibilities 
690 |a roles 
690 |a transplantation 
690 |a Pharmacy and materia medica 
690 |a RS1-441 
655 7 |a article  |2 local 
786 0 |n Pharmacy, Vol 8, Iss 1, p 3 (2020) 
787 0 |n https://www.mdpi.com/2226-4787/8/1/3 
787 0 |n https://doaj.org/toc/2226-4787 
856 4 1 |u https://doaj.org/article/8b2645c6130f47a092ed1c624b90922c  |z Connect to this object online.